Skip to main content

Table 2 Gene mutations, laboratory tests and clinical characteristics

From: Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte

Patient ID

Membrane gene mutation

Other mutation

OFT

PB spherocytes

Splenectomy

Family history of HS

Severity of HS

Additional tests with positive results

1

SPTB, EPB41

UGT1A1

NA

  

▲▲▲

SDS-PAGE (Spectrin)

2

ANK1

 

+

♦♦♦

 

(HA, father)

▲▲

 

3

SPTB

 

NA

♦♦

 

AD

▲▲▲

Flow cytometrya

4

SPTB

UGT1A1

+

♦♦

  

▲▲

 

5

  

+

♦♦

AD

▲▲▲

SDS-PAGE (Spectrin)

6

ANK1

 

♦♦

 

▲▲▲

SDS-PAGE (Spectrin)

7

SPTB

 

+

  

▲▲▲

 

8

SPTB, SPTA1

 

+

 

AD

▲▲▲

 

9

SPTB, SPTA1

 

NA

 

AD

▲▲▲

Flow cytometrya

10

  

+

♦♦

(HA, mother)

▲▲▲

 

11c

SPTB

UGT1A1

NA

♦♦♦

  

▲▲▲

 

12

ANK1

 

+

♦♦

 

▲▲▲

 

13

SPTB

UGT1A1

+

  

▲▲

 

14

  

+

AD

▲▲▲

 

15

ANK1 b

 

NA

♦♦

 

AD

▲▲

SDS-PAGE (Spectrin)

16

ANK1 b

UGT1A1

NA

♦♦♦

 

AD

▲▲▲

 

17

 

UGT1A1

+

♦♦♦

  

▲▲

 

18

ANK1

 

NA

♦♦♦

 

AD

▲▲▲

 

19

ANK1

UGT1A1, UGT1A1

+

♦♦

  

▲▲

 

20

SPTB, SPTA1

UGT1A1

♦♦

 

AD

▲▲▲

 

21c

SLC4A1 b

UGT1A1

NA

 

(HA, sibling)

▲▲

 

22

 

UGT1A1

+

 

AD

▲▲▲

 

23

SPTB

 

+

♦♦♦

 

AD

▲▲▲

 

24

 

UGT1A1

+

♦♦

 

(HA, mother)

▲▲▲

 

25c

ANK1 b

 

NA

♦♦♦

  

▲▲

 

26

ANK1

 

+

♦♦♦

AD

▲▲

 

27

ANK1

 

+

  

▲▲▲

 

28

SPTB

 

+

♦♦

AD

▲▲

 

29

ANK1 b

GSR

+

♦♦

  

▲▲

 

30

SPTB

ALDOB

+

♦♦♦

  

▲▲

 

31c

SPTB

NA

♦♦♦

  

▲▲▲

 

32

SLC4A1 b

UGT1A1, UGT1A1

+

♦♦♦

  

▲▲

 

33

SPTB

UGT1A1

+

♦♦

 

▲▲▲

 

34

SPTB

 

AD

▲▲

 

35

SPTB b , EPB42

UGT1A1

+

  

▲▲

Autohemolysis

36

SPTB

 

+

♦♦

 

▲▲

 

37

ANK1

 

+

♦♦

 

▲▲

 

38

 

UGT1A1

+

  

SDS-PAGE (Spectrin)

39c

ANK1

UGT1A1

  

 

40

SPTB

 

+

♦♦

 

▲▲▲

 

41

ANK1

 

+

♦♦♦

  

 

42

ANK1

 

+

♦♦

  

▲▲▲

 

43c

ANK1, ANK1

UGT1A1

NA

  

▲▲

 

44

SPTB,ANK1

UGT1A1

+

  

▲▲

 

45

ANK1

UGT1A1

+

♦♦♦

  

▲▲

 

46

SPTB

UGT1A1

+

♦♦♦

  

▲▲

 

47

SPTB

 

+

 

(HA, sibling)

▲▲▲

 

48c

SPTB b

 

NA

  

▲▲▲

 

49c

SPTB

UGT1A1

+

  

▲▲

 

50

ANK1

 

+

 

AD

▲▲

 

51

SPTB

UGT1A1

+

 

AD

▲▲

 

52

  

+

♦♦

  

▲▲

 

53

ANK1

 

+

  

 

54

  

AD

▲▲▲

 

55

SPTB

 

♦♦♦

 

AD

 

56

SLC4A1

UGT1A1, GAPDH

+

  

 

57

SPTB

 

+

♦♦♦

 

AD

▲▲▲

 

58

SPTB

UGT1A1

+

♦♦

 

AD

▲▲

 

59

SPTB

 

+

  

▲▲▲

 
  1. aFlow cytometry (OFT and EMA binding test), bPreviously reported variants (see Additional file 1: Table S3), cEight patients who did not meet the diagnostic criteria of HS without genetic testing
  2. PB spherocytes [20] ♦, 1+; ♦♦, 2+; ♦♦♦, 3+, Severity of HS [8] ▲, mild; ▲▲, moderate; ▲▲▲, severe
  3. Abbreviations: AD autosomal dominant, ALDOB aldolase B, ANK1 ankyrin 1, EPB41 erythrocyte membrane protein band 4.1, EPB42 erythrocyte membrane protein band 4.2, GAPDH glyceraldehyde-3-phosphate dehydrogenase, GSR glutathione reductase, HA hemolytic anemia, SLC4A1 solute carrier family 4, member 1, SPTA1 spectrin, alpha 1, SPTB spectrin, beta, UGT1A1, UDP glycosyltransferase 1 family, polypeptide A1, OFT osmotic fragility test, NA not assessable